Compugen (CGEN) Cash from Financing Activities (2009 - 2010)
Compugen (CGEN) posted quarterly Cash from Financing Activities of $890000.0 for Q4 2010, down 92.65% year-over-year from $12.1 million in Q4 2009, and up 947.06% on a QoQ basis from $85000.0 in Q3 2010.
Powered by 
Analysis
Compugen (CGEN) Cash from Financing Activities (2009 - 2010) Analysis & Trends
Compugen has reported Cash from Financing Activities for 2 years, with the latest figure at $890000.0 in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 14.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.42 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -6.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 36.24 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -273.15 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 27.18 Mn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | 890,000.00 |
| Sep 30, 2010 | 85,000.00 |
| Dec 31, 2009 | 12.10 Mn |